Karim Omar ElSaeed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karim Omar ElSaeed has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Emam
Department of Urology, Ain Shams University, Cairo, Egypt
2 shared publications A.M. Tawfeek
Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publicationAbdelrahman Mohamed Ismail
Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication- Ahmed Higazy
Urology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication - Ahmed Mohamed Tawfeek
Ain Shams University, Cairo, Egypt
1 shared publication Ahmed Radwan
Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication
Latest Publications
- 1 February 2025
- Published by SAGE Publications in Journal of Endourology
- Vol. 39 (2) , 166-171
Ejaculation-Preserving Transurethral Resection of the Prostate: A Randomized Controlled Trial
Objective: To evaluate the efficacy of preserving urethral mucosa around verumontanum in all directions and at the prostatic apex on antegrade ejaculation preservation and early postoperative continence in patients undergoing transurethral resection of the prostate (TURP). Materials and Methods: A randomized controlled trial was conducted in our tertiary center on patients scheduled for TURP. Patients were randomly allocated into two equal groups. Group A represented the control group who underwent conventional TURP, while Group B represented the ejaculation-sparing TURP. Patients were followed up for 3 months postoperatively to evaluate the voiding parameters and the preservation of antegrade ejaculation. Results: A total of 106 patients were evaluated in our study. Both groups were comparable regarding improvement in voiding parameters. Antegrade ejaculation was preserved in 44 patients (83%) of Group B compared with 10 patients (18.9%) in Group A with a highly statistically significant difference ( p < 0.001). Early postoperative urge urinary incontinence was lower in group B (5.7%) compared with (20.8%) in group A, with a statistically significant difference ( p = 0.02). Other perioperative parameters were compared between both groups. Conclusion: The ejaculation-sparing technique adopted in our study showed a promising result for preserving antegrade ejaculation following TURP with a success rate of 83%. Additionally, there was a lower incidence of early postoperative urge urinary incontinence.
- 1 February 2025
- Published by SAGE Publications in Journal of Endourology
- Vol. 39 (2) , 166-171
Ejaculation-Preserving Transurethral Resection of the Prostate: A Randomized Controlled Trial
Objective: To evaluate the efficacy of preserving urethral mucosa around verumontanum in all directions and at the prostatic apex on antegrade ejaculation preservation and early postoperative continence in patients undergoing transurethral resection of the prostate (TURP). Materials and Methods: A randomized controlled trial was conducted in our tertiary center on patients scheduled for TURP. Patients were randomly allocated into two equal groups. Group A represented the control group who underwent conventional TURP, while Group B represented the ejaculation-sparing TURP. Patients were followed up for 3 months postoperatively to evaluate the voiding parameters and the preservation of antegrade ejaculation. Results: A total of 106 patients were evaluated in our study. Both groups were comparable regarding improvement in voiding parameters. Antegrade ejaculation was preserved in 44 patients (83%) of Group B compared with 10 patients (18.9%) in Group A with a highly statistically significant difference ( p < 0.001). Early postoperative urge urinary incontinence was lower in group B (5.7%) compared with (20.8%) in group A, with a statistically significant difference ( p = 0.02). Other perioperative parameters were compared between both groups. Conclusion: The ejaculation-sparing technique adopted in our study showed a promising result for preserving antegrade ejaculation following TURP with a success rate of 83%. Additionally, there was a lower incidence of early postoperative urge urinary incontinence.
- Open Access
- 2 April 2024
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 34 (1) , 1-8
Combination of pregabalin and Amitriptyline in management of chronic idiopathic pain following penile prosthesis implantation: a pilot study
Background: Chronic post-penile prosthesis pain is de novo pain persisting > 2 months post-operatively. This pain is inadequately reported, poorly understood and undermanaged. The purpose of this current pilot study was to improvise a medical approach to alleviate the condition and assess the combination of Pregabalin and Amitriptyline in its management. Results: The study enrolled 9 patients complaining of idiopathic penile, pelvic, or scrotal pain persisting > 2 months after penile prosthesis implantation. Patients were prescribed pregabalin 75mg/12h (escalated after 1 week to 150mg/12h upon demand) and Amitriptyline 25mg once daily for 3 months. The pain was reassessed after 10, 30 and 100 days. The dose of pregabalin required and the side effects of the medication were noted. Findings revealed a significant decrease in pain duration (p = 0.007), frequency (p < 0.001), and intensity (p < 0.001); in glanular (p = 0.008), shaft pain (p = 0.046) but not scrotal (p = 0.112). Moreover, a significant decrease was found in sharp pain (p = 0.003) and pain aggravated by touch (p = 0.008) but not aching pain (p = 0.277). Additionally, significant improvement was reported in QoL (p < 0.001) and dose escalation of pregabalin to 150mg/12h was required in only 1 case (11%). Conclusion: The combination of pregabalin and amitriptyline is very effective in the management of chronic idiopathic pain following penile prosthesis implantation. However, due to the ambiguity and lack of reporting of the condition, we recommend a multicentric contribution to acknowledge the condition, and weigh its prevalence accurately, whilst evaluating the efficacy of our approach. This study received ethical approval from Ain Shams University Research Ethics Committee (REC) FWA 000017585, on 04/13/2023 (REC-FMASU@med.asu.edu.eg). Trial registration: no FMASU R98/2023.
- 2 April 2024
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 34 (1) , 1-8
Open AccessCombination of pregabalin and Amitriptyline in management of chronic idiopathic pain following penile prosthesis implantation: a pilot study
Background: Chronic post-penile prosthesis pain is de novo pain persisting > 2 months post-operatively. This pain is inadequately reported, poorly understood and undermanaged. The purpose of this current pilot study was to improvise a medical approach to alleviate the condition and assess the combination of Pregabalin and Amitriptyline in its management. Results: The study enrolled 9 patients complaining of idiopathic penile, pelvic, or scrotal pain persisting > 2 months after penile prosthesis implantation. Patients were prescribed pregabalin 75mg/12h (escalated after 1 week to 150mg/12h upon demand) and Amitriptyline 25mg once daily for 3 months. The pain was reassessed after 10, 30 and 100 days. The dose of pregabalin required and the side effects of the medication were noted. Findings revealed a significant decrease in pain duration (p = 0.007), frequency (p < 0.001), and intensity (p < 0.001); in glanular (p = 0.008), shaft pain (p = 0.046) but not scrotal (p = 0.112). Moreover, a significant decrease was found in sharp pain (p = 0.003) and pain aggravated by touch (p = 0.008) but not aching pain (p = 0.277). Additionally, significant improvement was reported in QoL (p < 0.001) and dose escalation of pregabalin to 150mg/12h was required in only 1 case (11%). Conclusion: The combination of pregabalin and amitriptyline is very effective in the management of chronic idiopathic pain following penile prosthesis implantation. However, due to the ambiguity and lack of reporting of the condition, we recommend a multicentric contribution to acknowledge the condition, and weigh its prevalence accurately, whilst evaluating the efficacy of our approach. This study received ethical approval from Ain Shams University Research Ethics Committee (REC) FWA 000017585, on 04/13/2023 (REC-FMASU@med.asu.edu.eg). Trial registration: no FMASU R98/2023.
- Open Access
- 14 January 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (6) , 1811-1816
Evaluation of Tamsulosin 0.4 mg versus 0.8 mg in management of lower urinary tract symptoms due to benign prostatic enlargement
Purpose: To compare the efficacy and the safety of Tamsulosin 0.4 mg/day and 0.8 mg/day in patients suffering from lower urinary tract symptoms due to benign prostatic obstruction. Patients and Methods: A prospective interventional, double-blinded, controlled study was carried out on 93 patients who met the criteria and divided randomly into two groups: group A for Tamsulosin 0.4 mg/day and group B for Tamsulosin 0.8 mg/day. International prostate symptom score, post void residual urine volume, and maximum flow rate of urine were assessed before and after 4 weeks of treatment. Results: Both study groups showed a significant reduction in storage sub-score but only frequency was significantly reduced in group B (P < 0.001). On the other hand, Tamsulosin 0.8 mg was superior to Tamsulosin 0.4 mg regarding voiding sub-score except for straining (P = 0.325). Accordingly, the total international prostate symptom score was significantly improved in group B versus group A (P < 0.001). Furthermore, maximum flow rate and post-void residual urine volume were notably improved in Group B as compared to Group A (P < 0.001). Of all adverse events only dizziness was noted to be statistically significant in Group B versus Group A (P < 0.001). Conclusion: Tamsulosin 0.8 mg has shown better outcomes in treating patients who suffer from lower urinary tract symptoms due to benign prostatic enlargement than Tamsulosin 0.4 mg, and besides that, it is well tolerated. Trial registration number: M S 292/2020, SID: 373, date: 22/4/2020.
- 14 January 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (6) , 1811-1816
Open AccessEvaluation of Tamsulosin 0.4 mg versus 0.8 mg in management of lower urinary tract symptoms due to benign prostatic enlargement
Purpose: To compare the efficacy and the safety of Tamsulosin 0.4 mg/day and 0.8 mg/day in patients suffering from lower urinary tract symptoms due to benign prostatic obstruction. Patients and Methods: A prospective interventional, double-blinded, controlled study was carried out on 93 patients who met the criteria and divided randomly into two groups: group A for Tamsulosin 0.4 mg/day and group B for Tamsulosin 0.8 mg/day. International prostate symptom score, post void residual urine volume, and maximum flow rate of urine were assessed before and after 4 weeks of treatment. Results: Both study groups showed a significant reduction in storage sub-score but only frequency was significantly reduced in group B (P < 0.001). On the other hand, Tamsulosin 0.8 mg was superior to Tamsulosin 0.4 mg regarding voiding sub-score except for straining (P = 0.325). Accordingly, the total international prostate symptom score was significantly improved in group B versus group A (P < 0.001). Furthermore, maximum flow rate and post-void residual urine volume were notably improved in Group B as compared to Group A (P < 0.001). Of all adverse events only dizziness was noted to be statistically significant in Group B versus Group A (P < 0.001). Conclusion: Tamsulosin 0.8 mg has shown better outcomes in treating patients who suffer from lower urinary tract symptoms due to benign prostatic enlargement than Tamsulosin 0.4 mg, and besides that, it is well tolerated. Trial registration number: M S 292/2020, SID: 373, date: 22/4/2020.
- 1 December 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (12) , 1254-1260
Comparison Between Mini-Percutaneous Nephrolithotomy and Standard Percutaneous Nephrolithotomy in Management of Large Renal Stones: A Randomized, Controlled Clinical Trial
Objectives: to compare between mini PNL and the standard PNL in management of renal stones (20-40 mm) regarding operative time, fluoroscopy time, blood loss, stone free rate, and postoperative complications. Subjects and methods: This prospective randomized comparative study was carried out on 93 patients divided into 2 groups: Group A included 44 patients who underwent standard PNL, whereas Group B included 49 patients who underwent mini PNL. Results: Standard PNL showed shorter operative time yet longer hospitalization, nephrostomy and catheterization time. The mean drop in hemoglobin level was significantly lower in the mini PNL group. In the first week postoperatively, stone-free rate was higher in the standard PNL group, but this was statistically insignificant. However, 4 weeks postoperatively, stone free rate was significantly higher in group A. The postoperative pain and the need for postoperative analgesia were significantly higher in standard PNL patients. Conclusions: Standard PNL achieved higher stone free rate and shorter operative time while mini PNL had the advantage of shorter hospitalization time and lower incidence of pain and postoperative complications.
- 1 December 2023
- Published by SAGE Publications in Journal of Endourology
- Vol. 37 (12) , 1254-1260
Comparison Between Mini-Percutaneous Nephrolithotomy and Standard Percutaneous Nephrolithotomy in Management of Large Renal Stones: A Randomized, Controlled Clinical Trial
Objectives: to compare between mini PNL and the standard PNL in management of renal stones (20-40 mm) regarding operative time, fluoroscopy time, blood loss, stone free rate, and postoperative complications. Subjects and methods: This prospective randomized comparative study was carried out on 93 patients divided into 2 groups: Group A included 44 patients who underwent standard PNL, whereas Group B included 49 patients who underwent mini PNL. Results: Standard PNL showed shorter operative time yet longer hospitalization, nephrostomy and catheterization time. The mean drop in hemoglobin level was significantly lower in the mini PNL group. In the first week postoperatively, stone-free rate was higher in the standard PNL group, but this was statistically insignificant. However, 4 weeks postoperatively, stone free rate was significantly higher in group A. The postoperative pain and the need for postoperative analgesia were significantly higher in standard PNL patients. Conclusions: Standard PNL achieved higher stone free rate and shorter operative time while mini PNL had the advantage of shorter hospitalization time and lower incidence of pain and postoperative complications.
- Open Access
- 28 November 2023
- Published by Springer Nature in Research Square
Combination of Pregabalin and Amitriptyline in Management of Chronic Idiopathic Pain Following Penile Prosthesis Implantation: A Pilot Study
Background: Chronic post penile prosthesis pain is de novo pain pain persisting > 2 months post-operatively. The topic is inadequately reported and poorly understood. Our purpose was to improvise a medical approach to alleviate the condition. Methods: This pilot study enrolled 9 patients complaining of idiopathic penile, pelvic, or scrotal pain persisting > 2 months after penile prosthesis implantation. Subjects with signs of infection, malposition or inappropriate size were excluded. We took detailed history regarding duration of pain episodes, frequency, location, character, aggravation by touch, intensity, impact on Quality of Life (QoL), any prior analgesics. Consented patients were prescribed pregabalin 75mg/12h (escalated after 1 week to 150mg/12h upon demand) and Amitriptyline 25mg once daily for 3 months. Pain was reassessed after 10, 30 and 100 days. Dose of pregabalin required and side effects of medication were noted. Results: Significant decrease in pain duration (p=0.007), frequency (p<0.001), and intensity (p<0.001); in glanular (p=0.008), shaft pain (p=0.046) but not scrotal (p=0.112); in sharp pain (p=0.003) and pain aggravated by touch (p=0.008) but not aching pain (p=0.277). Furthermore, significant improvement in QoL (p<0.001). Dose escalation of pregabalin to 150mg/12h required in 1 case (11%). Conclusion: The combination of pregabalin and amitriptyline is very effective in management of chronic idiopathic pain following penile prosthesis implantation. However due to the ambiguity and lack of reporting of the condition, we recommend a multicentric contribution to acknowledge the condition, weigh its prevalence accurately, whilst evaluating the efficacy of our approach. This study received ethical approval from Ain Shams University Research Ethics Committee (REC) FWA 000017585, on 04/13/2023 (REC-FMASU@med.asu.edu.eg). Trial Registration No.: FMASU R98/2023.
- 28 November 2023
- Published by Springer Nature in Research Square
Open AccessCombination of Pregabalin and Amitriptyline in Management of Chronic Idiopathic Pain Following Penile Prosthesis Implantation: A Pilot Study
Background: Chronic post penile prosthesis pain is de novo pain pain persisting > 2 months post-operatively. The topic is inadequately reported and poorly understood. Our purpose was to improvise a medical approach to alleviate the condition. Methods: This pilot study enrolled 9 patients complaining of idiopathic penile, pelvic, or scrotal pain persisting > 2 months after penile prosthesis implantation. Subjects with signs of infection, malposition or inappropriate size were excluded. We took detailed history regarding duration of pain episodes, frequency, location, character, aggravation by touch, intensity, impact on Quality of Life (QoL), any prior analgesics. Consented patients were prescribed pregabalin 75mg/12h (escalated after 1 week to 150mg/12h upon demand) and Amitriptyline 25mg once daily for 3 months. Pain was reassessed after 10, 30 and 100 days. Dose of pregabalin required and side effects of medication were noted. Results: Significant decrease in pain duration (p=0.007), frequency (p<0.001), and intensity (p<0.001); in glanular (p=0.008), shaft pain (p=0.046) but not scrotal (p=0.112); in sharp pain (p=0.003) and pain aggravated by touch (p=0.008) but not aching pain (p=0.277). Furthermore, significant improvement in QoL (p<0.001). Dose escalation of pregabalin to 150mg/12h required in 1 case (11%). Conclusion: The combination of pregabalin and amitriptyline is very effective in management of chronic idiopathic pain following penile prosthesis implantation. However due to the ambiguity and lack of reporting of the condition, we recommend a multicentric contribution to acknowledge the condition, weigh its prevalence accurately, whilst evaluating the efficacy of our approach. This study received ethical approval from Ain Shams University Research Ethics Committee (REC) FWA 000017585, on 04/13/2023 (REC-FMASU@med.asu.edu.eg). Trial Registration No.: FMASU R98/2023.
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (Supplement)
Comparative Study between Pneumatic and Holmium Laser Lithotripsy in Treatment of Ureteric Stones
Objective: The aim of this study was to compare the efficacy & safety of holmium laser and pneumatic lithotripsy used in the ureteroscopic treatment of ureteral stones. Materials and Methods: A prospective randomized clinical study was done using the data of patients to whom ureteroscopic lithotripsy (URL) was applied for ureter stones in our clinic. Then these patients were separated into 2 groups according to the type of lithotriptor used in stone fragmentation as laser lithotripsy (Group 1) and pneumatic lithotripsy (Group 2). Results: Statistically, the two groups were similar in respect of the number of stones, stone burden and the number of double J stents applied intra-operatively. Mean operating time was calculated as 62.9 (±7.69) minutes in Group 1 and 50.98 (±6.63) minutes in Group 2. The mean operating time was found to be higher in group 1 than group 2 (P = 0.000). On postoperative day 1 after the URL, the SFR of Group 1 79.0% found to be significantly high compared to the SFR of Group 2 (64.0%) (P = 0.019), while at postoperative month 1, the SFR of both groups (Group 1 84%, Group 2 80%) was found to be similar (P = 0.462). Conclusions: Compared to the pneumatic lithotripter, the Ho: YAG laser seems to have a statistically significant higher SFR in the early postoperative period (1 day), even though there are statistically insignificant success rate (after 1 month) and complications (hematuria, mucosa injury, stone migration, stricture and perforation avulsion).
- 1 October 2021
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (Supplement)
Open AccessComparative Study between Pneumatic and Holmium Laser Lithotripsy in Treatment of Ureteric Stones
Objective: The aim of this study was to compare the efficacy & safety of holmium laser and pneumatic lithotripsy used in the ureteroscopic treatment of ureteral stones. Materials and Methods: A prospective randomized clinical study was done using the data of patients to whom ureteroscopic lithotripsy (URL) was applied for ureter stones in our clinic. Then these patients were separated into 2 groups according to the type of lithotriptor used in stone fragmentation as laser lithotripsy (Group 1) and pneumatic lithotripsy (Group 2). Results: Statistically, the two groups were similar in respect of the number of stones, stone burden and the number of double J stents applied intra-operatively. Mean operating time was calculated as 62.9 (±7.69) minutes in Group 1 and 50.98 (±6.63) minutes in Group 2. The mean operating time was found to be higher in group 1 than group 2 (P = 0.000). On postoperative day 1 after the URL, the SFR of Group 1 79.0% found to be significantly high compared to the SFR of Group 2 (64.0%) (P = 0.019), while at postoperative month 1, the SFR of both groups (Group 1 84%, Group 2 80%) was found to be similar (P = 0.462). Conclusions: Compared to the pneumatic lithotripter, the Ho: YAG laser seems to have a statistically significant higher SFR in the early postoperative period (1 day), even though there are statistically insignificant success rate (after 1 month) and complications (hematuria, mucosa injury, stone migration, stricture and perforation avulsion).
- Open Access
- 1 September 2017
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 15 (3) , 260-266
Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria
To determine the preoperative, intraoperative and postoperative risk factors that influence the development of persistent post-transurethral resection of the prostate (TURP) urinary tract infection (UTI) defined as pyuria and/or bacteriuria remaining for 3 weeks after surgery. This is a prospective study including 100 patients scheduled for TURP. Urine analysis and culture was performed immediately after catheter removal, then at 1 and 3 weeks postoperatively, and the results were correlated to various preoperative, intraoperative and postoperative potential risk factors to detect any significant relation to persistent UTI. There was a statistically significant relationship between bacteriuria and the following risk factors: old age, past history of diabetes mellitus, large prostatic size, positive preoperative urine analysis and culture, preoperative catheter use, previous urological interventions, large size of sheath, long duration of operation, postoperative catheter events and postoperative manual wash. Many risk factors have been found to contribute to the development of post-TURP UTI and avoiding these factors can enhance recovery of patients undergoing TURP.
- 1 September 2017
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 15 (3) , 260-266
Open AccessEvaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria
To determine the preoperative, intraoperative and postoperative risk factors that influence the development of persistent post-transurethral resection of the prostate (TURP) urinary tract infection (UTI) defined as pyuria and/or bacteriuria remaining for 3 weeks after surgery. This is a prospective study including 100 patients scheduled for TURP. Urine analysis and culture was performed immediately after catheter removal, then at 1 and 3 weeks postoperatively, and the results were correlated to various preoperative, intraoperative and postoperative potential risk factors to detect any significant relation to persistent UTI. There was a statistically significant relationship between bacteriuria and the following risk factors: old age, past history of diabetes mellitus, large prostatic size, positive preoperative urine analysis and culture, preoperative catheter use, previous urological interventions, large size of sheath, long duration of operation, postoperative catheter events and postoperative manual wash. Many risk factors have been found to contribute to the development of post-TURP UTI and avoiding these factors can enhance recovery of patients undergoing TURP.